Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.81 |
| ▸ | CNR2 | P34972 | 2/20 | 0.81 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.58 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.50 |
| ▸ | BACE1 | P56817 | 2/20 | 0.49 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380189 | 0.90 | CNR1 (1.00) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL662610 | 0.90 | CNR1 (1.00) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL9625122 | 0.86 | CNR1 (0.61) | CNR1CNR2KDM4EALDH1A1CYP3A4 | |
| SCHEMBL12881959 | 0.86 | CNR1 (0.71) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL12881972 | 0.86 | CNR1 (0.71) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL12881304 | 0.86 | CNR1 (0.71) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL25383045 | 0.85 | CNR1 (0.88) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL4288864 | 0.85 | TRPA1 (0.57) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL28324597 | 0.84 | CNR1 (0.67) | CNR1CNR2ALOX5GABRA1GABRB2 | |
| SCHEMBL167391 | 0.84 | CNR1 (0.72) | CNR1CNR2ALOX5GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111040777-B | Liquid crystal composition and display element thereof | 西安近代化学研究所 | 2022-04-19 | — | — | CN | disclosed |
| CN-111040777-A | Liquid crystal composition and display element thereof | 西安近代化学研究所 | 2020-04-21 | — | — | CN | disclosed |
| US-8652444-B2 | Oral compositions containing biphenol antibacterial compounds | COLGATE-PALMOLIVE COMPANY (US) | 2014-02-18 | — | — | US | disclosed |
| EP-2266666-B1 | Oral compositions containing biphenol antibacterial compounds | COLGATE PALMOLIVE CO (US) | 2013-04-17 | — | — | EP | disclosed |
| US-20120052026-A1 | ORAL COMPOSITIONS CONTAINING BIPHENOL ANTIBACTERIAL COMPOUNDS | COLGATE-PALMOLIVE COMPANY (US) | 2012-03-01 | — | — | US | disclosed |
| EP-2266666-A1 | Oral compositions containing biphenol antibacterial compounds | Colgate-Palmolive Company (US) | 2010-12-29 | — | — | EP | disclosed |
| EP-1830925-A1 | ORAL COMPOSITIONS CONTAINING BIPHENOL ANTIBACTERIAL COMPOUNDS | Colgate-Palmolive Company (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006071654-A1 | ORAL COMPOSITIONS CONTAINING BIPHENOL ANTIBACTERIAL COMPOUNDS | COLGATE-PALMOLIVE COMPANY (US) | 2006-07-06 | — | — | WO | disclosed |
| US-20060140880-A1 | Oral compositions containing biphenol antibacterial compounds | COLGATE-PALMOLIVE | 2006-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052026-A1 | ORAL COMPOSITIONS CONTAINING BIPHENOL ANTIBACTERIAL COMPOUNDS | BPGM, ABCB11, UGT1A10 | CNR1 3087/4885CNR2 3431/4885ALOX5 2044/4885 |
| US-20060140880-A1 | Oral compositions containing biphenol antibacterial compounds | BPGM, ABCB11, UGT1A10 | CNR1 3087/4885CNR2 3431/4885ALOX5 2044/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.